Characterizing Myasthenia Gravis Symptoms, Exacerbations, and Crises From Neurologist's Clinical Notes Using Natural...

Area of Science:

• Neurology
• Clinical Research
• Real-World Evidence

Background:

• Myasthenia Gravis (MG) is a rare autoimmune neuromuscular disorder causing fatigable weakness.
• Administrative data may not capture the full clinical picture of MG.
• Free-text clinical notes offer deeper insights into MG patient care.

Purpose of the Study:

• To analyze neurologist progress notes for Myasthenia Gravis (MG) care.
• To document clinical subtypes, antibody status, symptoms, and deteriorations in MG.
• To categorize MG deteriorations and identify clinical inertia in MG management.

Main Methods:

• Retrospective, cross-sectional analysis of de-identified neurologist notes (2017-2022).
• Qualitative analysis of physician descriptions of MG deteriorations.
• Examination of documented risks associated with MG care and treatment.

Main Results:

• Analysis included 3,085 individuals with MG, detailing subtypes like generalized MG (gMG) and ocular MG.
• Common gMG symptoms included dysphagia, dyspnea, and dysarthria.
• MG crisis patients frequently showed difficulties with standard therapies; treatment toxicity and worsening symptoms were noted risks.

Conclusions:

• Neurologist notes are valuable for generating real-world evidence in Myasthenia Gravis (MG) care.
• MG patients experience variable symptoms and a range of clinical deteriorations.
• Frequent adverse effects of MG therapies highlight the need for improved, less toxic treatment options.